Table 1

Patient profiles and characteristics

Patient number/sex/age (years)

Disease duration (years)

Therapy

X-ray findings


Patients with rheumatoid arthritis

1/F/56

1

MTX, steroids

None

2/F/53

5

MTX, Inf, steroids

Erosions

3/F/46

4

MTX

Erosions

4/F/33

3

Hcq, MTX

Erosions

5/M/63

3

Lef

Erosions, osteopenia

6/F/52

2

Lef, steroids

Erosions

7/F/40

6

Etanercept

Erosions

8/F/50

6

Lef

Erosions

Patients with systemic lupus erythematosus

11/F/68

1

Hcq, steroids

None

12/F/46

5

Hcq

None

13/F/25

5

Hcq

None

14/F/47

9

Hcq, MTX

None

15/F/22

5

Hcq, steroids

Jaccoud's arthropathy

16/F/38

6

Hcq, steroids

None

17/F/46

4

Hcq, steroids

None

18/F/55

10

Hcq, steroids

None

19/F/45

3

Hcq, steroids

None

20/F/61

18

Hcq

None

21/F/35

5

Hcq, MTX, steroids

None

22/F/53

8

Hcq

None


F, female; Hcq, hydroxychloroquine; Inf, infliximab; Lef, leflunomide; M, male; MTX, methotrexate.

Maldonado et al. Arthritis Res Ther 2003 5:R91-R96   doi:10.1186/ar619

Open Data